Richard Francis (president) and (CEO) Sol Barer (chairman) Eli Kalif (CFO)
Revenue
US$ 15.85 Billion (2023)
Operating income
US$ 1.715 Billion (2021)[2]
Net income
US$ -0.559 Billion (2023)
Total assets
US$ 47.666 Billion (2021)[3]
Total equity
US$ 11.244 Billion (2021)[4]
Number of employees
35,000 (2023)
Website
tevapharm.com teva.co.il
Günther Friedländer, founder of Teva Pharmaceutical Industries in Jerusalem
Teva Pharmaceutical Industries Ltd. (also known as Teva Pharmaceuticals) is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients (API's) and, to a lesser extent, contract manufacturing services and an out-licensing platform.
Teva's primary branded products include Austedo (deutetrabenazine) which is used for the treatment of chorea associated with Huntington's disease and tardive dyskinesia; and Ajovy (fremanezumab), used for the preventive treatment of migraine in adults. Additional branded drugs sold by Teva include Copaxone, Bendeka and Treanda, all of which are primarily sold in the United States.
Teva is listed on the Tel Aviv Stock Exchange and the New York Stock Exchange. Its manufacturing facilities are located in Israel, North America, Europe, Australia, and South America. The company is a member of the Pharmaceutical Research and Manufacturers of America (PhRMA).[5][6]
Teva Pharmaceuticals is the largest generic drug manufacturer in the world. Overall, Teva is the 18th largest pharmaceutical company in the world.[7] Teva has a history of legal trouble in relation to collusion and price-fixing to inflate prices for drugs.[8] In 2023, Teva paid the largest fine to date for a domestic antitrust cartel in relation to a criminal investigation by the US Department of Justice into the company's price-fixing.[9]
^"TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Israel Company Reports – Search Israeli Companies". www.israelbizreg.com. Retrieved October 19, 2016.
^"Teva Pharmaceutical Industries Operating Income 2010-2022".
^"Teva Pharmaceutical Industries Total Assets 2010-2022".
TevaPharmaceutical Industries Ltd. (also known as TevaPharmaceuticals) is an Israeli multinational pharmaceutical company. Teva specializes primarily...
Pharmaceutical industry in India Torrent Pharmaceuticals Zydus Lifesciences Cadila Pharmaceuticals Alembic Pharmaceuticals Century Pharmaceuticals "Intas...
Teva API is an international pharmaceutical company headquartered in Israel. Teva API is a stand-alone business unit of TevaPharmaceutical Industries...
Miami pharmaceutical manufacturer Ivax Corporation from 1987. He sold Ivax in January 2006, for $7.4 billion, to Israel-based TevaPharmaceuticals. Frost...
Retrieved March 2, 2018. "Teva buys Barr Pharmaceuticals". The Jerusalem Post | JPost.com. Retrieved 2018-11-18. "Barr Pharmaceuticals, Inc. History". FundingUniverse...
Pharmaceuticals acquired Pliva. On December 23, 2008, Barr Pharmaceuticals was acquired by TevaPharmaceuticals and the company became part of Teva Active...
known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on...
2000, when it was acquired by TevaPharmaceuticals. At the time, Novopharm was Canada's second largest drug manufacturer. Teva, a generic drug manufacturer...
The top 5 best selling pharmaceuticals 2015–2019. Sales in billion USD. The top 16 best selling pharmaceuticals of 2017/18. Drugs with sales above $5 billion...
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Pune. Emcure's product portfolio includes tablets, capsules...
its generic drugs business, Actavis, to TevaPharmaceuticals for $40.5 billion. In June 2019, U.S. pharmaceutical company AbbVie announced it had reached...
of famciclovir. Generic tablets are manufactured by TEVAPharmaceuticals and Mylan Pharmaceuticals. Famciclovir is indicated for the treatment of herpes...
Technology in Israel and the drug company, TevaPharmaceuticals, identified the R-isomer as the active form of the drug. Teva brought it to market in partnership...
available in the United States in generic from one manufacturer, TevaPharmaceuticals and is manufactured in Israel. Nefazodone is used to treat major...
1300%. In 2010, a jury in Las Vegas, Nevada, ordered Baxter and TevaPharmaceuticals to pay $144 million to patients who had been infected with hepatitis...
third-largest generic and pharmaceuticals company in the United States to the second-largest generic and specialty pharmaceuticals company in the world. Mylan...
Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is a global biopharmaceutical company with a focus on oncology and...
abbreviated new drug application (ANDA) 90-589, submitted by TevaPharmaceuticals (Teva), for an epinephrine auto-injector". US Government Dockets Repository...
expiration, several drug manufacturers, including Roxane Labs, Sandoz and TevaPharmaceuticals, announced that they were launching generic Naratriptan medications...
the largest pharmaceutical company in Sweden. Its British counterpart, Zeneca PLC was formed in 1993 when ICI divested its pharmaceuticals businesses;...
TevaPharmaceutical Industries Ltd Pharmaceutical Industries Ltd. Archived from the original on 8 October 2018. Retrieved 7 October 2018. "Teva's AJOVY...
Global Information
US$ 15.85 Billion (2023)
US$ 11.244 Billion (2021)[4]